Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
:PLX
Total Valuation
Protalix has a market cap or net worth of $202.88M. The enterprise value is $113.29M.
Market Cap$202.88M
Enterprise Value$113.29M
Share Statistics
Protalix has 78.03M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding78.03M
Owned by Insiders1.12%
Owned by Instutions0.91%
Financial Efficiency
Protalix’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.61%.
Return on Equity (ROE)6.79%
Return on Assets (ROA)3.99%
Return on Invested Capital (ROIC)5.61%
Return on Capital Employed (ROCE)8.20%
Revenue Per Employee$250,699.531
Profits Per Employee$13,765.258
Employee Count213
Asset Turnover0.73
Inventory Turnover1.14
Valuation Ratios
The current PE Ratio of Protalix is 46.51. Protalix’s PEG ratio is -0.70.
PE Ratio46.51
PS Ratio2.55
PB Ratio3.16
Price to Fair Value3.16
Price to FCF18.45
Price to Operating Cash Flow15.72
PEG Ratio-0.70
Income Statement
In the last 12 months, Protalix had revenue of $53.40M and earned $2.93M in profits. Earnings per share was -$0.01.
Revenue$53.40M
Gross Profit$29.08M
Operating Income$3.92M
Pretax Income$4.15M
Net Income$2.93M
EBITDA6.52M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was $8.67M and capital expenditures -$1.28M, giving a free cash flow of $7.39M billion.
Operating Cash Flow$8.67M
Free Cash Flow$7.39M
Free Cash Flow per Share$0.09
Dividends & Yields
Protalix pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield5.42%
Earnings Yield2.15%
Stock Price Statistics
Beta0.42
52-Week Price Change126.96%
50-Day Moving Average2.45
200-Day Moving Average1.66
Relative Strength Index (RSI)58.76
Average Volume (3m)739.05K
Important Dates
Protalix upcoming earnings date is May 9, 2025, TBA.
Last Earnings DateMar 17, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend Date―
Financial Position
Protalix as a current ratio of 2.34, with Debt / Equity ratio of 0.13
Current Ratio2.34
Quick Ratio1.52
Debt to Market Cap0.04
Net Debt to EBITDA-2.18
Interest Coverage Ratio3.69
Taxes
In the past 12 months, Protalix has paid $1.22M in taxes.
Income Tax$1.22M
Effective Tax Rate29.42%
Enterprise Valuation
Protalix EV to EBITDA ratio is 18.73, with an EV/FCF ratio of 16.52.
EV to Sales2.29
EV to EBITDA18.73
EV to Free Cash Flow16.52
EV to Operating Cash Flow14.08
Balance Sheet
Protalix has $34.83M in cash and marketable securities with $5.53M in debt, giving a net cash position of -$29.30M billion.
Cash & Marketable Securities$34.83M
Total Debt$5.53M
Net Cash-$29.30M
Net Cash Per Share-$0.38
Tangible Book Value Per Share$0.60
Margins
Gross margin is 54.46%, with operating margin of 7.34%, and net profit margin of 5.49%.
Gross Margin54.46%
Operating Margin7.34%
Pretax Margin7.78%
Net Profit Margin5.49%
EBITDA Margin12.21%
EBIT Margin9.77%
Analyst Forecast
The average price target for Protalix is $15.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$15.00
Price Target Upside474.71%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-18.47%
EPS Growth Forecast-70.64%